| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 281.997 | 87 |
| GSM780708 | Untreated after 4 days (C2_1) | 299.396 | 87 |
| GSM780709 | Untreated after 4 days (C3_1) | 217.45 | 84 |
| GSM780719 | Untreated after 4 days (C1_2) | 296.844 | 87 |
| GSM780720 | Untreated after 4 days (C2_2) | 286.761 | 87 |
| GSM780721 | Untreated after 4 days (C3_2) | 226.51 | 85 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 340.096 | 88 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 239.593 | 85 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 474.346 | 91 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 374.963 | 89 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 236.214 | 85 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 448.218 | 91 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 186.692 | 83 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 267.535 | 86 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 263.951 | 86 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 183.35 | 83 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 254.782 | 86 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 235.037 | 85 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 279.116 | 87 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 261.96 | 86 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 292.838 | 87 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 286.044 | 87 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 250.173 | 86 |